Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 6, 2007 - Issue 1
Submit an article Journal homepage
281
Views
7
CrossRef citations to date
0
Altmetric
Editorial

Insulin glulisine: efficacy and safety compared with other rapid-acting insulin analogues

Ali D Kamal Consultant Physician, Birmingham Heartlands Hospital NHS Foundation Trust, Birmingham B9 5SS, UK
&
Stephen C Bain Professor of Medicine (Diabetes), University of Wales Swansea, Department of Medicine, Singleton Park, Swansea, SA2 8PP, UK
Pages 5-7 | Published online: 20 Dec 2006

Bibliography

  • RAVE K, KLEIN O, FRICK AD, BECKER RH: Advantage of premeal-injected insulin glulisine compared with regular human insulin in subjects with Type 1 diabetes. Diabetes Care (2006) 29(8):1812-1817.
  • APIDRA: Summary of Product Characteristics. Sanofi. July (2005).
  • DREYER M, PRAGER R, ROBINSON A et al.: Efficacy and safety of insulin glulisine in patients with Type 1 diabetes. Horm. Metab. Res. (2005) 37(11):702-707.
  • DAILEY G, ROSENSTOCK J, MOSES RG, WAYS K: Insulin glulisine provides improved glycemic control in patients with Type 2 diabetes. Diabetes Care (2004) 27(10):2363-2368.
  • DANNE T, BECKER RH, HEISE T, BITTNER C, FRICK AD, RAVE K: Pharmacokinetics, prandial glucose control, and safety of insulin glulisine in children and adolescents with Type 1 diabetes. Diabetes Care (2005) 28(9):2100-2105.
  • HOOGMA RP, SCHUMICKI D: Safety of insulin glulisine when given by continuous subcutaneous infusion using an external pump in patients with Type 1 diabetes. Horm. Metab. Res. (2006) 38(6):429-433.
  • STAMMBERGER I, SEIPKE G, BARTELS T: Insulin glulisine – a comprehensive preclinical evaluation. Int. J. Toxicol. (2006) 25(1):25-33.
  • HENNIGE AM, STRACK V, METZINGER E, SEIPKE G, HARING HU, KELLERER M: Effects of new insulin analogues HMR-1964 (insulin glulisine) and HMR-1423 on insulin receptors. Diabetologia (2005) 48(9):1891-1897.
  • SANOFI-AVENTIS: HMR-1964 Investigator’s brochure.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.